Starbucks expected to build on US sales momentum as investors eye 2027 outlook

UBS forecasts Starbucks fiscal Q4 North American same-store sales growth of 7.5%, above the 6.7% consensus, and EPS of $0.77–$0.82 versus $0.72 consensus. Investors will look for evidence the turnaround can sustain momentum as recent tailwinds fade; Starbucks is expected to report on October 29.

Analysis

The key issue is whether sales momentum is repeatable, not whether one bank’s above-consensus forecast proves accurate. A headline beat could still disappoint if it relies on short-lived demand or pricing effects, or if management signals weaker forward trends. The more durable positive would be transaction-led growth alongside stable margin commentary; that would support confidence in the turnaround and reduce the risk that investors treat the quarter as a peak. Conversely, sales strength accompanied by heavier discounting, weaker traffic, or cautious guidance would raise the possibility that growth is being bought at the expense of profitability. In the next few days, the October 29 report is the catalyst; over 1–3 months, follow-through in comparable sales and margin guidance matters more than the print. Over 6–18 months, sustained customer demand and execution—not a single quarter—would be needed to justify a lasting re-rating. Competitors such as McDonald’s and Dutch Bros could benefit if Starbucks’ growth proves price- or promotion-dependent, but the article provides no evidence yet of share shifts. The contrarian risk is that a result near UBS’s forecast may be treated as a clear win even if the underlying sales mix or outlook is less durable.

Key Decisions for Investors

• Avoid adding SBUX solely ahead of the report: the estimate gap is not independently verified, and earnings carry event risk.
• After results, consider a staged long only if management supports continued comparable-sales momentum with evidence of transaction strength and no material deterioration in margin outlook.
• Treat a result below the cited consensus benchmarks—6.7% North American comparable-sales growth or $0.72 EPS—or a clear forward-guidance reset as a thesis warning; reassess rather than averaging down.
• Monitor sales mix, traffic/transactions, promotional intensity, and forward margin commentary. If growth appears dependent on discounting or fades quickly, the turnaround premium may be vulnerable; absent those details, there is no compelling pair or options trade.